Skip to main content

Body Image

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Group-based TherapyN/A1 trial
Active Trials
NCT03259347Completed534Est. Apr 2018
NewBridge Pharmaceuticals
1 program
Practical Body ImageN/A1 trial
Active Trials
NCT04064255Completed40Est. Jul 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NewBridge PharmaceuticalsPractical Body Image
Oregon TherapeuticsGroup-based Therapy

Clinical Trials (2)

Total enrollment: 574 patients across 2 trials

Evaluation of Practical Body Image Therapy for Anorexia Nervosa V1

Start: Sep 2016Est. completion: Jul 201840 patients
N/ACompleted

Eating Disorders Programs: An Indicated Trial

Start: Jun 2012Est. completion: Apr 2018534 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.